Cargando…

Management of cutaneous disorders related to inflammatory bowel disease

Almost one-third of patients with inflammatory bowel disease (IBD) develop skin lesions. Cutaneous disorders associated with IBD may be divided into 5 groups based on the nature of the association: specific manifestations (orofacial and metastatic IBD), reactive disorders (erythema nodosum, pyoderma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellicer, Zaira, Santiago, Jesus Manuel, Rodriguez, Alejandro, Alonso, Vicent, Antón, Rosario, Bosca, Marta Maia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2012
Materias:	Invited Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959344/ https://www.ncbi.nlm.nih.gov/pubmed/24713996

Ejemplares similares

Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines
por: Hernández, Vicent, et al.
Publicado: (2012)

HLA-DQ: Celiac disease vs inflammatory bowel disease
por: Bosca-Watts, Marta Maia, et al.
Publicado: (2018)

Electrolyte and acid-base disorders in inflammatory bowel disease
por: Barkas, Fotis, et al.
Publicado: (2013)

Diagnosis and natural history of preclinical and early inflammatory bowel disease
por: Rodríguez-Lago, Iago, et al.
Publicado: (2020)

Management of iron deficiency anemia in inflammatory bowel disease – a practical approach
por: Stein, Jürgen, et al.
Publicado: (2013)

Intestinal Ultrasound Is the Ideal Patient-Centric, Point-of-Care Tool for Clinical Decision Making in the Inflammatory Bowel Disease Practice
por: Dolinger, Michael Todd, et al.
Publicado: (2023)

Rheumatological manifestations in inflammatory bowel disease
por: Voulgari, Paraskevi V.
Publicado: (2011)

The history of genetics in inflammatory bowel disease
por: Ek, Weronica E., et al.
Publicado: (2014)

The use of ultrasound in inflammatory bowel disease
por: Kucharzik, Torsten, et al.
Publicado: (2017)

Endocrine and metabolic manifestations in inflammatory bowel disease
por: Tigas, Stelios, et al.
Publicado: (2012)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Familial and ethnic risk in inflammatory bowel disease
por: Santos, Maria Pia Costa, et al.
Publicado: (2018)

Role of bile acids in inflammatory bowel disease
por: Tiratterra, Elisa, et al.
Publicado: (2018)

Bile Acid Signaling in Inflammatory Bowel Diseases
por: Fiorucci, Stefano, et al.
Publicado: (2020)

Psychological factors associated with inflammatory bowel disease
por: Eugenicos, M P, et al.
Publicado: (2021)

The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021
por: Skamnelos, Alexandros, et al.
Publicado: (2021)

An overview of lipid abnormalities in patients with inflammatory bowel disease
por: Agouridis, Aris P., et al.
Publicado: (2011)

Clostridium difficile infection in patients with inflammatory bowel disease
por: Saidel-Odes, Lisa, et al.
Publicado: (2011)

Manipulating bone disease in inflammatory bowel disease patients
por: Miheller, Pal, et al.
Publicado: (2013)

Epidemiology of intrafamilial inflammatory bowel disease throughout Europe
por: Arias-Loste, Maria Teresa, et al.
Publicado: (2012)

Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
por: Kim, Mi Jin, et al.
Publicado: (2013)

Diagnosis and treatment of anemia in patients with inflammatory bowel disease
por: Mücke, Victoria, et al.
Publicado: (2017)

Advances in the development of new biologics in inflammatory bowel disease
por: Ungar, Bella, et al.
Publicado: (2016)

Treatment of Pyoderma Gangrenosum in Pediatric Inflammatory Bowel Disease
por: Vaidy, Katherine, et al.
Publicado: (2020)

Update on current applications of proteomic in the study of inflammatory bowel disease
por: Roda, Giulia, et al.
Publicado: (2012)

Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer
por: Jauregui-Amezaga, Aranzazu, et al.
Publicado: (2016)

Adipokines and the role of visceral adipose tissue in inflammatory bowel disease
por: Karrasch, Thomas, et al.
Publicado: (2016)

The European Perspective and History on Biosimilars for the Treatment of Inflammatory Bowel Diseases
por: Solitano, Virginia, et al.
Publicado: (2021)

Telenutrition for Inflammatory Bowel Disease: A Tipping Point for Dietary Wellness
por: Elamin, Sami, et al.
Publicado: (2021)

Bioelectronics in the brain–gut axis: focus on inflammatory bowel disease (IBD)
por: Stakenborg, Nathalie, et al.
Publicado: (2021)

Segmental colitis associated with diverticulosis: is it the coexistence of colonic diverticulosis and inflammatory bowel disease?
por: Schembri, John, et al.
Publicado: (2017)

Management of small bowel angioectasias diagnosed during video capsule endoscopy
por: Sciberras, Nicole, et al.
Publicado: (2023)

Breaking the Therapeutic Ceiling: Dual Biologic or Small Molecule Therapy for Refractory Inflammatory Bowel Disease
por: Ahmed, Waseem
Publicado: (2022)

Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?
por: Hart, Lara, et al.
Publicado: (2022)

Switching from Infliximab to Biosimilar in Inflammatory Bowel Disease: A Review of Existing Literature and Best Practices
por: Bhat, Shubha, et al.
Publicado: (2021)

Optimizing Medication Access and Use in Inflammatory Bowel Disease: The Roles and Impact of Clinical Pharmacists and Pharmacy Technicians
por: Bhat, Shubha
Publicado: (2023)

Taking a JAB at How Gastroenterologists Can Increase Vaccination Rates in Patients with Inflammatory Bowel Disease
por: Almasry, Mazen, et al.
Publicado: (2023)

Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders
por: de Bortoli, Nicola, et al.
Publicado: (2018)

Early‐onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms
por: Pazmandi, Julia, et al.
Publicado: (2018)

Management of patients with Intestinal Bowel Disease and COVID-19: A review of current evidence and future perspectives
por: Suria, Carles, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e5scb9idjsk23bd23ptg40f0pb